DICE Therapeutics, Inc.
DICE · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $461 | $116 | $60 | $8 |
| Short-Term Investments | $113 | $203 | $0 | $18 |
| Receivables | $0 | $2 | $2 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $3 | $0 | $0 |
| Total Curr. Assets | $578 | $324 | $62 | $29 |
| Property Plant & Equip (Net) | $16 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $16 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $594 | $326 | $64 | $31 |
| Liabilities | – | – | – | – |
| Payables | $3 | $2 | $5 | $1 |
| Short-Term Debt | $1 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $1 |
| Other Curr. Liab. | $11 | $9 | $3 | $2 |
| Total Curr. Liab. | $15 | $11 | $9 | $4 |
| LT Debt | $12 | $2 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $1 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $56 |
| Total NC Liab. | $12 | $2 | $108 | $57 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $27 | $13 | $117 | $61 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $326 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$188 | -$104 | -$55 | -$31 |
| AOCI | -$1 | -$0 | $0 | $0 |
| Other Equity | $1 | -$326 | $2 | $1 |
| Total Equity | -$188 | -$104 | -$53 | -$30 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | -$161 | -$91 | $64 | $31 |
| Net Debt | -$448 | -$113 | -$60 | -$8 |